[18-F]- FDG - PET for Cervical Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cervical Cancer[18-F]- FDG - PET - DiagnosticTest
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial will test how well the FDG-PET scan and blood tests for HPV can detect leftover cervical cancer cells after treatment.

Eligible Conditions
  • Cervical Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: up to 5 years

Up to 3 months
Plasma HPV DNA levels
up to 5 years
Progression-free survival rate

Trial Safety

Trial Design

1 Treatment Group

FDG PET Scan
1 of 1

Experimental Treatment

64 Total Participants · 1 Treatment Group

Primary Treatment: [18-F]- FDG - PET · No Placebo Group · N/A

FDG PET Scan
DiagnosticTest
Experimental Group · 1 Intervention: [18-F]- FDG - PET · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years

Who is running the clinical trial?

Sunnybrook Health Sciences CentreOTHER
604 Previous Clinical Trials
1,469,123 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,380 Previous Clinical Trials
473,375 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: